Can the Rally in Ocular Therapeutix (OCUL) Shares Continue?

Ocular Therapeutix, Inc. OCUL has been on the move lately as the stock has risen by 38% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on OCUL is moving in the right direction. In fact, the stock currently has a Zacks Rank #2 (Buy), suggesting that the recent run could certainly continue for this in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

 Zacks Editor-in-Chief Goes ""All In"" on This Stock

Full disclosure, Kevin Matras now has more of his own money in one particular stock than in any other. He believes in its short-term profit potential and also in its prospects to more than double by 2019. Today he reveals and explains his surprising move in a new Special Report.

Download it free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ocular Therapeutix, Inc. (OCUL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research